Clinical Trials
57
Participants
Ixazomib Citrate With Gemcitabine Hydrochloride and Doxorubicin Hydrochloride in Treating Patients With Urothelial Cancer That is Metastatic or Cannot Be Removed by Surgery
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2015-07-03
Completion:
2025-12-31
Conditions
Metastatic Urothelial Carcinoma
Transitional Cell Carcinoma
Unresectable Transitional Cell Carcinoma
Interventions
DRUG
No Results Yet
166
Participants
A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2015-03-06
Completion:
2016-12-07
Conditions
Advanced Malignancies That Harbor IDHR132 Mutations
Interventions
DRUG
No Results Yet
60
Participants
Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents Pulmonary MDR-TB
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2016-05-03
Completion:
2027-02-11
Conditions
Multidrug-Resistant Tuberculosis
Interventions
DRUG
No Results Yet
10
Participants
Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2015-11-20
Completion:
2026-09-08
Conditions
AIDS-Related Burkitt Lymphoma
AIDS-Related Diffuse Large B-cell Lymphoma
AIDS-Related Plasmablastic Lymphoma
AIDS-Related Primary Effusion Lymphoma
HIV Infection
AIDS Related Non-Hodgkin Lymphoma
Interventions
DRUG
BIOLOGICAL
No Results Yet
37
Participants
Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2016-06-22
Completion:
2026-12-31
Conditions
ALK Positive
Locally Advanced Malignant Solid Neoplasm
Metastatic Malignant Solid Neoplasm
ROS1 Gene Rearrangement
Stage IIIB Lung Non-Small Cell Cancer AJCC v7
Stage IV Lung Non-Small Cell Cancer AJCC v7
Interventions
DRUG
OTHER
No Results Yet
81
Participants
Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2015-05-28
Completion:
2020-11-06
Conditions
Recurrent Breast Carcinoma
Stage III Breast Cancer AJCC v7
Stage IIIA Breast Cancer AJCC v7
Stage IIIB Breast Cancer AJCC v7
Stage IIIC Breast Cancer AJCC v7
Stage IV Breast Cancer AJCC v6 and v7
Interventions
DRUG
OTHER
2000
Participants
Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer
Study Type:
OBSERVATIONAL
Last Updated:
2025-11-10
Start Date:
2014-09-16
Completion:
2026-09-16
Conditions
Malignant Neoplasm
Interventions
OTHER
No Results Yet
236
Participants
Phase II Study of IRD (Ixazomib, Lenalidomide, Dexamethasone) Post Autologous Stem Cell Transplantation Followed by Maintenance Ixazomib or Lenalidomide for Multiple Myeloma
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2015-01-20
Completion:
2020-02-05
Conditions
Multiple Myeloma
Interventions
BIOLOGICAL
DRUG
104
Participants
Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by Surgery
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2014-11-25
Completion:
2025-12-31
Conditions
Clear Cell Renal Cell Carcinoma
Metastatic Kidney Carcinoma
Stage IV Renal Cell Cancer AJCC v7
Interventions
BIOLOGICAL
PROCEDURE
OTHER
No Results Yet
140
Participants
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2014-07-11
Completion:
2019-06-30
Conditions
Alveolar Soft Part Sarcoma
Angiomatoid Fibrous Histiocytoma
Atypical Fibroxanthoma
Clear Cell Sarcoma of Soft Tissue
Epithelioid Malignant Peripheral Nerve Sheath Tumor
Epithelioid Sarcoma
Extraskeletal Myxoid Chondrosarcoma
Extraskeletal Osteosarcoma
Fibrohistiocytic Neoplasm
Fibrosarcoma
Inflammatory Myofibroblastic Tumor
Intimal Sarcoma
Leiomyosarcoma
Liposarcoma
Liver Embryonal Sarcoma
Low Grade Fibromyxoid Sarcoma
Low Grade Myofibroblastic Sarcoma
Malignant Peripheral Nerve Sheath Tumor
Malignant Skin Granular Cell Tumor
Malignant Triton Tumor
Mesenchymal Chondrosarcoma
Myxofibrosarcoma
Myxoid Chondrosarcoma
Myxoinflammatory Fibroblastic Sarcoma
Nerve Sheath Neoplasm
PEComa
Pericytic Neoplasm
Plexiform Fibrohistiocytic Tumor
Sclerosing Epithelioid Fibrosarcoma
Skin Glomus Tumor
Stage IB Soft Tissue Sarcoma AJCC v7
Stage IIB Soft Tissue Sarcoma AJCC v7
Stage III Soft Tissue Sarcoma AJCC v7
Stage IV Soft Tissue Sarcoma AJCC v7
Synovial Sarcoma
Undifferentiated High Grade Pleomorphic Sarcoma of Bone
Interventions
DRUG
RADIATION
PROCEDURE
606
Participants
Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2014-12-04
Completion:
2025-12-31
Conditions
Glioblastoma
Interventions
RADIATION
OTHER
DRUG
No Results Yet
57
Participants
A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2014-07-09
Completion:
2016-06-27
Conditions
Prostatic Neoplasms
Metastatic Castration-Resistant Prostate Cancer
Interventions
DRUG
No Results Yet
700
Participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
Study Type:
OBSERVATIONAL
Last Updated:
2025-11-10
Start Date:
2014-03-11
Completion:
2028-03-30
Conditions
Epilepsy
Interventions
DEVICE
No Results Yet
488
Participants
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2014-05-19
Completion:
2023-06-23
Conditions
Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
Interventions
PROCEDURE
BIOLOGICAL
DRUG
80
Participants
Feasibility Study for Fibroblast Autologous Skin Grafts
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2015-01-07
Completion:
2027-12-02
Conditions
Wounds and Injuries
Interventions
BIOLOGICAL
No Results Yet
200
Participants
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2016-12-31
Completion:
2026-02-28
Conditions
Acute Myeloid Leukemia (AML)
Acute Lymphocytic Leukemia (ALL)
Chronic Myelogenous Leukemia
Plasma Cell Leukemia
Myelofibrosis
Myelodysplasia
Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma
Marginal Zone B-Cell Lymphoma
Follicular Lymphoma
Lymphoplasmacytic Lymphoma
Mantle-Cell Lymphoma
Prolymphocytic Leukemia
Diffuse Large B Cell Lymphoma
Lymphoblastic Lymphoma
Burkitt's Lymphoma
Non-Hodgkin Lymphoma
Multiple Myeloma
Interventions
DRUG
RADIATION
BIOLOGICAL
No Results Yet
39
Participants
Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2013-09-24
Completion:
2024-11-06
Conditions
Recurrent Diffuse Large B-Cell Lymphoma
Recurrent Follicular Lymphoma
Recurrent Lymphoplasmacytic Lymphoma
Recurrent Mantle Cell Lymphoma
Recurrent Marginal Zone Lymphoma
Refractory Diffuse Large B-Cell Lymphoma
Refractory Follicular Lymphoma
Refractory Lymphoplasmacytic Lymphoma
Refractory Mantle Cell Lymphoma
Refractory Marginal Zone Lymphoma
Interventions
PROCEDURE
DRUG
No Results Yet
169
Participants
Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2014-01-24
Completion:
2021-10-06
Conditions
Stage IIIC Cutaneous Melanoma AJCC v7
Stage IV Cutaneous Melanoma AJCC v6 and v7
Unresectable Melanoma
Interventions
BIOLOGICAL
150
Participants
Links Between Inflammation and Cardiometabolic Diseases
Study Type:
OBSERVATIONAL
Last Updated:
2025-11-10
Start Date:
2013-12-02
Completion:
2022-08-03
Conditions
Diabetes Mellitus
Cardiovascular Disease
Healthy Volunteer
Inflammation
Interventions
DRUG
No Results Yet
10
Participants
Islet Cell Transplant for Type 1 Diabetes
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2013-10-16
Completion:
2026-09-22
Conditions
Type 1 Diabetes Mellitus
Interventions
BIOLOGICAL
DRUG
No Results Yet
547
Participants
Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2014-01-15
Completion:
2018-08-07
Conditions
Stage I Chronic Lymphocytic Leukemia
Stage II Chronic Lymphocytic Leukemia
Stage III Chronic Lymphocytic Leukemia
Stage IV Chronic Lymphocytic Leukemia
Interventions
DRUG
PROCEDURE
OTHER
BIOLOGICAL
159
Participants
Multimodal Neuroimaging Genetic Biomarkers of Nicotine AddictionSeverity
Study Type:
OBSERVATIONAL
Last Updated:
2025-11-10
Start Date:
2013-11-06
Completion:
2024-06-29
Conditions
Nicotine Dependence
No Results Yet
349
Participants
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2013-08-27
Completion:
2020-03-26
Conditions
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma
Ann Arbor Stage III Diffuse Large B-Cell Lymphoma
Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma
Interventions
DRUG
OTHER
BIOLOGICAL
15
Participants
MIBG for Refractory Neuroblastoma and Pheochromocytoma
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2013-12-31
Completion:
2025-10-20
Conditions
Relapsed Neuroblastoma
Metastatic Pheochromocytoma
Interventions
DRUG
PROCEDURE
No Results Yet
171
Participants
Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2013-09-20
Completion:
2019-03-05
Conditions
Foregut Neuroendocrine Tumor
Hindgut Neuroendocrine Tumor
Metastatic Digestive System Neuroendocrine Tumor G1
Metastatic Neuroendocrine Tumor
Midgut Neuroendocrine Tumor G1
Neuroendocrine Tumor G2
Recurrent Digestive System Neuroendocrine Tumor G1
Regional Digestive System Neuroendocrine Tumor G1
Interventions
PROCEDURE
OTHER
DRUG
700
Participants
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2013-09-09
Completion:
2026-12-31
Conditions
Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma
Mantle Cell Lymphoma
Follicular Lymphoma
Diffuse Large B-cell Lymphoma
Waldenstrom Macroglobulinemia
Chronic Graft Versus Host Disease
Interventions
DRUG
No Results Yet
1542
Participants
Survivorship of Attune Primary Total Knee Prosthesis
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2013-02-01
Completion:
2030-02-01
Conditions
Noninflammatory Degenerative Joint Disease
Interventions
DEVICE
No Results Yet
1334
Participants
A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2012-11-09
Completion:
2017-04-20
Conditions
Hodgkin Lymphoma
Interventions
DRUG
125
Participants
Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2013-02-13
Completion:
2015-08-14
Conditions
Recurrent Lung Non-Small Cell Carcinoma
Stage IV Lung Non-Small Cell Cancer AJCC v7
Interventions
DRUG
OTHER
68
Participants
Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2014-01-15
Completion:
2025-12-31
Conditions
Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm
Sleep Disorder
Interventions
OTHER
DRUG
PROCEDURE
No Results Yet
25
Participants
AAV2-GDNF for Advanced Parkinson s Disease
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2013-03-13
Completion:
2022-02-04
Conditions
Parkinson's Disease
Interventions
GENETIC
No Results Yet
28
Participants
Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2016-08-17
Completion:
2026-08-31
Conditions
Severe Combined Immunodeficiency Disease, X-linked
Interventions
GENETIC
DRUG
DEVICE
No Results Yet
700
Participants
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Study Type:
OBSERVATIONAL
Last Updated:
2025-11-10
Start Date:
2011-09-09
Completion:
2018-12-02
Conditions
Breast Cancer
No Results Yet
44
Participants
Acute Changes in Endothelial Function in Germ Cell Tumor Patients Treated With Cisplatin and Untreated Germ Cell Tumor Controls
Study Type:
OBSERVATIONAL
Last Updated:
2025-11-10
Start Date:
2011-10-11
Completion:
2026-10-31
Conditions
Germ Cell Cancer
Interventions
OTHER
No Results Yet
120
Participants
Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2011-12-12
Completion:
2025-11-30
Conditions
Leukemia
Lymphoma
Interventions
DRUG
No Results Yet
40
Participants
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2012-09-25
Completion:
2032-12-31
Conditions
X-linked Severe Combined Immunodeficiency (XSCID)
Interventions
BIOLOGICAL
DRUG
No Results Yet
1328
Participants
Evaluation and Diagnosis of Potential Research Subjects With Traumatic Brain Injury
Study Type:
OBSERVATIONAL
Last Updated:
2025-11-10
Start Date:
2013-01-10
Conditions
Traumatic Brain Injury
No Results Yet
135
Participants
Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2011-04-28
Completion:
2017-05-24
Conditions
Ann Arbor Stage III Grade 1 Follicular Lymphoma
Ann Arbor Stage III Grade 2 Follicular Lymphoma
Ann Arbor Stage III Grade 3 Follicular Lymphoma
Ann Arbor Stage IV Grade 1 Follicular Lymphoma
Ann Arbor Stage IV Grade 2 Follicular Lymphoma
Ann Arbor Stage IV Grade 3 Follicular Lymphoma
Grade 3a Follicular Lymphoma
Interventions
DRUG
RADIATION
OTHER
BIOLOGICAL
PROCEDURE
1673
Participants
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2011-05-25
Completion:
2019-02-15
Conditions
Melanoma of Unknown Primary
Recurrent Melanoma
Stage IIIB Cutaneous Melanoma AJCC v7
Stage IIIC Cutaneous Melanoma AJCC v7
Stage IV Cutaneous Melanoma AJCC v6 and v7
Interventions
BIOLOGICAL
OTHER
5018
Participants
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2011-01-15
Completion:
2023-02-01
Conditions
Breast Ductal Carcinoma In Situ
Invasive Breast Carcinoma
Multicentric Breast Carcinoma
Multifocal Breast Carcinoma
Synchronous Bilateral Breast Carcinoma
Interventions
DRUG
OTHER
Showing 40 trials per page ยท Total 557382 trials